Street View: Lilly locks in heart treatment portfolio with Verve buyout
** Eli Lilly LLY.N will acquire gene-editing startup Verve Therapeutics VERV.O for up to $1.3 billion, the companies said on Tuesday, accelerating a push into experimental cardiovascular therapies
** Median PT of brokerages covering LLY is $972.50 - data compiled by LSEG
A BOOST TO GENE EDITING SPACE
** Evercore ISI says Lilly acquiring Verve is a welcome boost to the gene editing space, which has been under pressure for the last few years
** Cantor Fitzgerald ("overweight", PT:"$975") says the deal is centered primarily on adding VERV's PCSK9 gene editing program, VERV-102, to LLY's cardiovascular portfolio
** RBC Capital Markets says the deal reiterates pharma's appetite to have a multi-modality approach to cardiovascular diseases
** Leerink Partners ("outperform") says although the acquisition fits with LLY's cardiometabolic and genetic medicine R&D efforts, the path to approval and the ability to justify high reimbursement are unclear
Related Articles
Why You Should Watch the Bank of Japan’s Rate Hikes? Has the Yen Lost Its Safe-Haven Status?
TradingKey - In global capital markets, the Bank of Japan's policy moves and yen exchange rate trends are often key indicators for investment decisions. In many cases, BOJ actions can influence global stock, bond, and currency markets, such as when a BOJ rate hike triggers international capital flow
June FOMC meeting: Fed Holds Steady Amid Crosscurrents, Why Inaction May Be the Best Policy for Now
TradingKey - On June 18, the Federal Reserve released the June FOMC statement as scheduled, maintaining the benchmark interest rate at 4.25%–4.50%, in line with market expectations. After Powell's speech, the market quickly digested. The latest dot plot shows that the probability of the Federal...
BOJ June Meeting Preview: 2025 Rate Hikes Off the Table; Slowdown in Bond Purchase Cuts?
TradingKey - On Tuesday, June 17, 2025, the Bank of Japan (BOJ) will hold its monetary policy meeting. The market widely expects that the policy interest rate will remain unchanged at 0.5%. The key focus ahead of the meeting is likely to be how quickly the BOJ will reduce its pace of scaling back...
[IN-DEPTH ANALYSIS] LULU: Can it Recover from the Drop?
TradingKey - Thesis Among the stocks of the twenty largest clothing companies by revenue, Lululemon has the fifth lowest forward PE ratio. With all the negative sentiment revolving around the stock, we believe their multiple should be higher.
